Vvus stock earnings report

View today's stock price, news and analysis for VIVUS Inc. (VVUS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

VVUS Stock Price & Charts | VIVUS In depth view into VVUS (VIVUS) stock including the latest price, news, dividend history, earnings information and financials. VVUS:NASDAQ GS Stock Quote - VIVUS Inc - Bloomberg Markets Stock analysis for VIVUS Inc (VVUS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. VIVUS Inc. Stock Price (VVUS) | Barron's View today's stock price, news and analysis for VIVUS Inc. (VVUS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Vivus, Inc. (VVUS): Earnings Could Make or Break Vivus ...

VVUS VIVUS, Inc. Stock Quote - FINVIZ.com VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in VVUS - Vivus Stock Price - Barchart.com Vivus Inc (VVUS) [[ item.lastPrice Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. Today's Top Click the "See More" link to see the full Performance Report page with expanded historical information. Vivus (VVUS) Stock Message Board - InvestorsHub Mar 26, 2020 · VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10- K for the year ended December 31, 2006 and periodic reports filed with the Securities and Exchange Commission. CONTACT: VIVUS, Inc. Timothy E. Morris, 650-934-5200 Chief Financial Officer or

VVUS Stock Price and Chart — NASDAQ:VVUS — TradingView

Vivus Inc VVUS - Quotes, Financials, News, Charts and ... VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine Vivus, Inc. (VVUS): Earnings Could Make or Break Vivus ... Feb 20, 2015 · The Vivus, Inc. (VVUS) earnings report coming Monday could be a harsh reality check about the long-term prospects for Qsymia. Vivus stock holders beware. VVUS VIVUS, Inc. Stock Quote - FINVIZ.com VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in VVUS - Vivus Stock Price - Barchart.com

Vivus Inc Stock Quote: VVUS Stock News, Quotes, Analysis ...

Mar 26, 2020 · - Company to host conference call today at 4:30pm ET - VIVUS (VVUS), Inc. , a biopharmaceutical company, today reported financial results for the quarter and fiscal year ended December 31, 2019 and provided a business update. Fiscal year 2019 represents our first full year of operating results as a fully integrated business and clinical team, said John Amos, VIVUS Chief … VVUS - VIVUS, Inc. Summary, Stock Quote and News | Benzinga Jan 01, 2010 · VIVUS, Inc. (NASDAQ: VVUS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. VIVUS (VVUS) Stock Price History | wallmine VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA. VVUS Stock Price Quote & News - VIVUS | Robinhood View the real-time VVUS price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare VIVUS against related stocks people have also bought like CHK, INPX, GE, and NIO. 2,078 people own VIVUS on Robinhood on March 31, 2020.

Vivus Inc (VVUS) [[ item.lastPrice Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. Today's Top Click the "See More" link to see the full Performance Report page with expanded historical information.

VVUS | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for VIVUS INC (VVUS), including profile, stock chart, recent news and events, analyst opinions, and research reports. VVUS | Stock Snapshot - … Vivus Inc. (VVUS) Earnings - Stock Options Trading Tools Find stock price reaction to earnings announcements for Vivus Inc. (VVUS). Table displays both upcoming quarterly earnings dates and historical release dates as well as stock price changes, if available. For stocks that list options, compare implied volatility before and after earnings dates, as well as the option market's expected versus actual price movement. Vivus Inc Stock Quote: VVUS Stock News, Quotes, Analysis ... Nov 05, 2019 · VVUS, Vivus Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Vivus Inc Stock Quote: VVUS Stock News, Quotes, Analysis | Investors.com

Vivus Stock Chart and Information. NASDAQ: VVUS. Apr 6, 2020 4:00 PM EDT. Price: $1.31